Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Tuesday. The firm set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Stock Down 1.6 %

Shares of NASDAQ:RKDA opened at $6.20 on Tuesday. The company has a 50-day moving average price of $3.83 and a two-hundred day moving average price of $3.23. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The firm has a market capitalization of $8.46 million, a PE ratio of -1.45 and a beta of 1.18.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.